BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Treatment
27 results:

  • 1. Comparative analysis of chemical profiles, antioxidant, antibacterial, and anticancer effects of essential oils of two Thymus species from Montenegro.
    Preljević K; Pašić I; Vlaović M; Matić IZ; Krivokapić S; Petrović N; Stanojković T; Živković V; Perović S
    Fitoterapia; 2024 Apr; 174():105871. PubMed ID: 38428618
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. More than cervical cancer: Understanding racial/ethnic disparities in oropharyngeal cancer outcomes among males by HPV status.
    Villalona S; Ferrante J; Villalona S; Stroup A
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696662
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
    Shi L; Liu Y; Li J; Kou J; Ouyang Y; Chen F; Huang X; Huo L; Huang L; Cao X
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5999-6007. PubMed ID: 36624190
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of potential crucial genes and key pathways shared in Inflammatory Bowel Disease and cervical cancer by machine learning and integrated bioinformatics.
    Nguyen TB; Do DN; Nguyen-Thi ML; Hoang-The H; Tran TT; Nguyen-Thanh T
    Comput Biol Med; 2022 Oct; 149():105996. PubMed ID: 36049413
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven cancers.
    Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
    Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Impact of Pathologic Residual Tumor in Locally Advanced cervical cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study.
    Federico A; Anchora LP; Gallotta V; Fanfani F; Cosentino F; Turco LC; Bizzarri N; Legge F; Teodorico E; Macchia G; Valentini V; Scambia G; Ferrandina G
    Ann Surg Oncol; 2022 Aug; 29(8):4806-4814. PubMed ID: 35355131
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Post-recurrence survival in patients with cervical cancer.
    Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
    Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
    He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
    Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM.
    Samper Ots PM; Rovirosa Casino A; Herreros Martínez A; Rodriguez Villalba S; Pérez Calatayud J; Polo Cezón R; Gutiérrez Miguélez C; Anchuelo Latorre J; Rodríguez Rodríguez I; Córdoba Largo S; Pérez Echagüen S; Sanz Freire CJ; Clemente Gutiérrez F; De Las Peñas Cabrera D; Villafranca Iturre E;
    Clin Transl Oncol; 2021 Jun; 23(6):1193-1200. PubMed ID: 33237447
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Association between MRI histogram features and treatment response in locally advanced cervical cancer treated by chemoradiotherapy.
    Perucho JAU; Wang M; Tse KY; Ip PPC; Siu SWK; Ngan HYS; Khong PL; Lee EYP
    Eur Radiol; 2021 Mar; 31(3):1727-1735. PubMed ID: 32885298
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of the surgical approach on survival outcomes in patients undergoing radical hysterectomy for cervical cancer: A real-world multicenter study of a large Chinese cohort from 2006 to 2017.
    Guo C; Tang X; Meng Y; Zhang Y; Zhang X; Guo J; Lei X; Qiu J; Hua K
    Cancer Med; 2020 Aug; 9(16):5908-5921. PubMed ID: 32628356
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis.
    Zou W; Han Y; Zhang Y; Hu C; Feng Y; Zhang H; Wang J
    PLoS One; 2019; 14(11):e0225264. PubMed ID: 31725793
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
    Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
    [No Abstract]    [Full Text] [Related]  

  • 14. Downregulation of Mad2 and bubr1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis.
    Wang L; Wang J; Jin Y; Zheng J; Yang Y; Xi X
    J Obstet Gynaecol Res; 2019 Dec; 45(12):2407-2418. PubMed ID: 31523901
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer.
    Yang B; Xu Y; Zhu Q; Xie L; Shan W; Ning C; Xie B; Shi Y; Luo X; Zhang H; Chen X
    Gynecol Oncol; 2019 Apr; 153(1):55-62. PubMed ID: 30674421
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association of Metformin Use and Survival Outcome in Women With cervical cancer.
    Takiuchi T; Machida H; Hom MS; Mostofizadeh S; Frimer M; Brunette LL; Matsuo K
    Int J Gynecol Cancer; 2017 Sep; 27(7):1455-1463. PubMed ID: 29049093
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Matsuo K; Shimada M; Aoki Y; Sakamoto M; Takeshima N; Fujiwara H; Matsumoto T; Mikami M; Sugiyama T
    Int J Cancer; 2017 Sep; 141(5):1042-1051. PubMed ID: 28524247
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Analysis of Conservative Surgical treatment and Prognosis of Microinvasive Squamous Cell Carcinoma of the Cervix Stage IA1: Results of Follow-Up to 20 Years.
    Hartman CA; Teixeira JC; Barbosa SB; Figueiredo SM; Andrade LA; Bastos JF
    Int J Gynecol Cancer; 2017 Feb; 27(2):357-363. PubMed ID: 27984378
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National cancer Data Base.
    Haque W; Verma V; Fakhreddine M; Hatch S; Butler EB; Teh BS
    Gynecol Oncol; 2017 Jan; 144(1):28-33. PubMed ID: 27784533
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting of tubulin polymerization and induction of mitotic blockage by Methyl 2-(5-fluoro-2-hydroxyphenyl)-1H-benzo[d]imidazole-5-carboxylate (MBIC) in human cervical cancer HeLa cell.
    Hasanpourghadi M; Karthikeyan C; Pandurangan AK; Looi CY; Trivedi P; Kobayashi K; Tanaka K; Wong WF; Mustafa MR
    J Exp Clin Cancer Res; 2016 Mar; 35():58. PubMed ID: 27030360
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.